On February 1, 2022 Eli Lilly and Company (NYSE: LLY) reported that it will participate in the Guggenheim Oncology Conference on Wednesday, Feb. 9, 2022 (Press release, Eli Lilly, FEB 1, 2022, View Source [SID1234607564]). Jake Van Naarden, CEO of Loxo Oncology at Lilly and president, Lilly Oncology and David Hyman, M.D., chief medical officer, Lilly Oncology, will participate in a virtual fireside chat at 12 p.m., Eastern time .

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 90 days.